$2.26T
Total marketcap
$127.55B
Total volume
BTC 50.03%     ETH 15.48%
Dominance

Stayble Therapeutics AB (publ) STABL.ST Stock

0.24 SEK {{ price }} -1.666664% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
7.49M SEK
LOW - HIGH [24H]
0.23 - 0.24 SEK
VOLUME [24H]
6.4K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.01 SEK

Stayble Therapeutics AB (publ) Price Chart

Stayble Therapeutics AB (publ) STABL.ST Financial and Trading Overview

Stayble Therapeutics AB (publ) stock price 0.24 SEK
Previous Close 1.32 SEK
Open 1.34 SEK
Bid 1.25 SEK x N/A
Ask 1.29 SEK x N/A
Day's Range 1.25 - 1.34 SEK
52 Week Range 1.2 - 5.52 SEK
Volume 292.44K SEK
Avg. Volume 127.96K SEK
Market Cap 40.9M SEK
Beta (5Y Monthly) 0.924592
PE Ratio (TTM) N/A
EPS (TTM) -1.01 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

STABL.ST Valuation Measures

Enterprise Value 12.93M SEK
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.5799257
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stayble Therapeutics AB (publ) Stock Price History

Beta (5Y Monthly) 0.924592
52-Week Change -69.23%
S&P500 52-Week Change 20.43%
52 Week High 5.52 SEK
52 Week Low 1.2 SEK
50-Day Moving Average 1.5 SEK
200-Day Moving Average 3.17 SEK

STABL.ST Share Statistics

Avg. Volume (3 month) 127.96K SEK
Avg. Daily Volume (10-Days) 97.68K SEK
Shares Outstanding 31.72M
Float 12.88M
Short Ratio N/A
% Held by Insiders 13.40%
% Held by Institutions 9.10%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -47.49%
Return on Equity (ttm) -95.31%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) 0.02 SEK
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -20677000 SEK
Diluted EPS (ttm) -1.44
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 6.2M SEK
Total Cash Per Share (mrq) 0.45 SEK
Total Debt (mrq) 850K SEK
Total Debt/Equity (mrq) 7.61 SEK
Current Ratio (mrq) 2.538
Book Value Per Share (mrq) 0.807

Cash Flow Statement

Operating Cash Flow (ttm) -26919000 SEK
Levered Free Cash Flow (ttm) -19690500 SEK

Profile of Stayble Therapeutics AB (publ)

Country Sweden
State N/A
City Gothenburg
Address Arvid Hedvalls Backe 4
ZIP 411 33
Phone N/A
Website https://www.staybletherapeutics.se
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 3

Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.

Q&A For Stayble Therapeutics AB (publ) Stock

What is a current STABL.ST stock price?

Stayble Therapeutics AB (publ) STABL.ST stock price today per share is 0.24 SEK.

How to purchase Stayble Therapeutics AB (publ) stock?

You can buy STABL.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Stayble Therapeutics AB (publ)?

The stock symbol or ticker of Stayble Therapeutics AB (publ) is STABL.ST.

Which industry does the Stayble Therapeutics AB (publ) company belong to?

The Stayble Therapeutics AB (publ) industry is Biotechnology.

How many shares does Stayble Therapeutics AB (publ) have in circulation?

The max supply of Stayble Therapeutics AB (publ) shares is 31.72M.

What is Stayble Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?

Stayble Therapeutics AB (publ) PE Ratio is now.

What was Stayble Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?

Stayble Therapeutics AB (publ) EPS is -1.01 SEK over the trailing 12 months.

Which sector does the Stayble Therapeutics AB (publ) company belong to?

The Stayble Therapeutics AB (publ) sector is Healthcare.

Stayble Therapeutics AB (publ) STABL.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77